


<!DOCTYPE html>
<html lang="en">
<head><script src="//archive.org/includes/analytics.js?v=cf34f82" type="text/javascript"></script>
<script type="text/javascript">window.addEventListener('DOMContentLoaded',function(){var v=archive_analytics.values;v.service='wb';v.server_name='wwwb-app29.us.archive.org';v.server_ms=600;archive_analytics.send_pageview({});});</script><script type="text/javascript" src="/static/js/wbhack.js?v=1531166943.0" charset="utf-8"></script>

<script type="text/javascript">
__wbhack.init('https://web.archive.org/web');
</script>
<link rel="stylesheet" type="text/css" href="/static/css/banner-styles.css?v=1531166943.0" />
<link rel="stylesheet" type="text/css" href="/static/css/iconochive.css?v=1531166943.0" />

<!-- End Wayback Rewrite JS Include -->  

        <title>Attention-deficit hyperactivity disorder. | National Guideline Clearinghouse</title>

    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width">
    <link rel="icon" href="/web/20180712183206im_/https://www.guideline.gov/UI/images/favicon-NGC.ico">
    <link rel="apple-touch-icon" sizes="180x180" href="/web/20180712183206im_/https://www.guideline.gov/UI/images/apple-touch-icon-NGC.png">
    <link rel="icon" type="image/png" href="/web/20180712183206im_/https://www.guideline.gov/UI/images/favicon-NGC-32x32.png" sizes="32x32">
    <link rel="icon" type="image/png" href="/web/20180712183206im_/https://www.guideline.gov/UI/images/favicon-NGC-16x16.png" sizes="16x16">
    <link rel="manifest" href="/web/20180712183206/https://www.guideline.gov/UI/images/manifest-NGC.json">
    <link rel="mask-icon" href="/web/20180712183206im_/https://www.guideline.gov/UI/images/safari-pinned-tab-NGC.svg" color="#1d4345">
    <meta name="theme-color" content="#ffffff">
    
<link href="/web/20180712183206cs_/https://www.guideline.gov/cassette.axd/stylesheet/8382974d7bae1577062376dcd37102348398fe04/NGCSiteCSS" type="text/css" rel="stylesheet"/>
<!--[if lt IE 9]>
<link href="/cassette.axd/stylesheet/2188ac5b8507764bb4079068f7a3c8d7ccfba0e7/ieCSS" type="text/css" rel="stylesheet"/>
<![endif]-->



    <script async type="text/javascript" id="_fed_an_ua_tag" src="https://web.archive.org/web/20180712183206js_/https://dap.digitalgov.gov/Universal­-Federated-­Analytics-­Min.js?agency=HHS&amp;subagency=AHRQ"></script>
    </head>
<body class="no-js content-page">
<a href="#main-content" id="skip-nav">Skip to main content</a>
<!--https://developers.google.com/tag-manager/devguide#multidomain  ECH-1199-->
    
    <!-- Google Tag Manager -->
    <noscript>
        <iframe src="//web.archive.org/web/20180712183206if_/https://www.googletagmanager.com/ns.html?id=GTM-W4NX5V" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180712183206/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-W4NX5V');</script>

    <noscript>
        <iframe src="//web.archive.org/web/20180712183206if_/https://www.googletagmanager.com/ns.html?id=GTM-KHDP6Z" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180712183206/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-KHDP6Z');</script>
    <!-- End Google Tag Manager -->


    <!-- AHRQ HEADER -->
<div id="ahrq-header">

	<p class="hhs-links">
		<a href="https://web.archive.org/web/20180712183206/http://www.hhs.gov/" target="_blank" class="logo-hhs"><span class="logomark"></span>U.S.&nbsp;Department of&nbsp;Health&nbsp;and Human&nbsp;Services</a>
		<a href="https://web.archive.org/web/20180712183206/http://www.hhs.gov/" target="_blank" class="external-link"><strong>HHS.gov</strong></a>
	</p><!-- /.hhs-links -->
	<p class="ahrq-links">
		<a href="https://web.archive.org/web/20180712183206/http://www.ahrq.gov/" target="_blank" class="logo-ahrq">Agency for Healthcare Research and Quality: Advancing Excellence in Health Care</a>
		<a href="https://web.archive.org/web/20180712183206/http://www.ahrq.gov/" target="_blank" class="external-link"><strong>AHRQ.gov</strong></a>
	</p><!-- /.ahrq-links -->

</div><!-- /#ahrq-header -->

	<!-- HEADER -->
	<div class="header" id="header">
		<div class="masthead">

			<ul class="header-actions">
				<li><a href="#header-search" class="search-action"><span class="label">Search</span></a></li>
				<li><a href="#header-account" class="account-action"><span class="label">Account</span></a></li>
				<li><a href="#main-nav" class="menu-action"><span class="label">Menu</span></a></li>
			</ul><!-- /.header-actions -->
				
				<a href="/web/20180712183206/https://www.guideline.gov/" class="header-logo NGC">
				    <picture>
				        <source media="(min-width: 960px)" srcset="/web/20180712183206im_/https://www.guideline.gov/UI/images/logo_NGC_header.png">
				        <source srcset="/web/20180712183206im_/https://www.guideline.gov/UI/images/logo_NGC_header_m.png">
				        <img src="/web/20180712183206im_/https://www.guideline.gov/UI/images/logo_NGC_header.png" alt="National Guideline Clearinghouse">
				    </picture>
				</a>
<form action="/web/20180712183206/https://www.guideline.gov/search" class="header-search header-action" enctype="multipart/form-data" id="header-search" method="get">					<p class="search-bar">
						<label for="q"><span class="screen-reader-text">Search</span>
							<input id="q" type="text" title="Search Input" name="q" class="search-input" placeholder="Search">
						</label>
						<input id="masthead-search-button" type="submit" title="Search Submit" class="search-submit" value="Search">
					</p>
					<p class="search-tips">
						<a href="/web/20180712183206/https://www.guideline.gov/help-and-about/search-browse/search-tips">Search Tips</a>
					</p>
</form>				<div class="header-account header-action" id="header-account">
				<a id="login-button" class="signin" href="/web/20180712183206/https://www.guideline.gov/accounts/signinlanding" aria-role="tab" aria-controls="login-panel" aria-selected="false">Log into My NGC</a>
<div id="login-panel" class="login dropdown" aria-role="tab-panel" aria-labeledby="login-button" aria-hidden="true">
    
            <div class="sign-in">
            <form id="sign-in-form" action="/web/20180712183206/https://www.guideline.gov/Accounts/LoginSubmit" method="post">
                <h3>Sign In</h3>
                <div class="errormessages"></div>
                <p class="invalid-user-cred message-block" style="display: none;"></p>
                <p>
                    <label for="sign-in-username">Username or Email <span class="required">*</span></label>
                    <input type="text" id="sign-in-username" class="input-text" name="email" required>
                   
                </p>
                <p>
                    <label for="sign-in-userpwd">Password <span class="required">*</span></label>
                    <input type="password" id="sign-in-userpwd" class="input-text" name="password" required>
                  
                </p>
                <p class="form-link"><a href="/web/20180712183206/https://www.guideline.gov/accounts/forgotpassword">Forgot Password?</a></p>
                <p><label for="remember-me"><input type="checkbox" name="remember-me" id="remember-me">Remember Me</label></p>
                <input id="account-sign-in" type="submit" value="Sign In"/>
            </form>
            <p>
                <label for="sign-up-btn">Don't have an account?</label>
                <a href="/web/20180712183206/https://www.guideline.gov/accounts/login" class="sign-up-btn" id="sign-up-btn">Create New Account</a>
            </p>
        </div><!--/.sign-in-->
</div><!-- /.login -->
				</div><!-- /.header-account -->
		</div><!-- /.masthead -->

		<div class="main-nav header-action" id="main-nav">
		    <ul class="level-1">
		        <li class=""><a href="/web/20180712183206/https://www.guideline.gov/">Home</a></li>
		        <li class=""><a href="/web/20180712183206/https://www.guideline.gov/new-this-week/index">New This Week</a></li>
		        <li>
<a href="/web/20180712183206/https://www.guideline.gov/summaries/browse" class="parent-link">Guideline Summaries</a>                    		            <ul class="level-2 dropdown">
                             <li class=""><a href="/web/20180712183206/https://www.guideline.gov/browse/clinical-specialty">By Clinical Specialty</a></li>
		                <li class=""><a href="/web/20180712183206/https://www.guideline.gov/browse/organization">By Organization</a></li>
		                <li class=""><a href="/web/20180712183206/https://www.guideline.gov/browse/mesh-tag">By MeSH Tag</a></li>
		                <li class=""><a href="/web/20180712183206/https://www.guideline.gov/summaries/in-progress">In Progress</a></li>
		                <li class=""><a href="/web/20180712183206/https://www.guideline.gov/summaries/archive">Archive</a></li>

		                <li class=""><a href="/web/20180712183206/https://www.guideline.gov/search?f_DocType=0&amp;fLockTerm=Guideline Summaries">All Summaries</a></li>
		            </ul>
		        </li>
<li class=""><a href="/web/20180712183206/https://www.guideline.gov/syntheses/index">Guideline Syntheses</a></li>		        <li class=""><a href="/web/20180712183206/https://www.guideline.gov/expert">Expert Commentaries</a></li>
		        <li class=""><a href="/web/20180712183206/https://www.guideline.gov/matrix">Matrix Tool</a></li>
		        <li class="">
<a href="/web/20180712183206/https://www.guideline.gov/summaries/submit">Submit Guidelines</a>                    		        </li>
                <li class=""><a href="/web/20180712183206/https://www.guideline.gov/help-and-about">Help &amp;&nbsp;About</a></li>		      
		    </ul>
		</div><!-- /.main-nav -->
</div><!-- /.header -->

    <br/><div class="content"><div class="fundingNotice2"><b>The AHRQ National Guideline Clearinghouse (NGC, guideline.gov) Web site will not be available after July 16, 2018</b> because federal funding <br/>through AHRQ will no longer be available to support the NGC as of that date. For additional information, read our <a href="/web/20180712183206/https://www.guideline.gov/home/announcements">full announcement</a>.</div></div>

	<!-- CONTENT -->
	<main id="main-content" tabindex="-1">
		

<div class="main">

		<div class="aside-container">

	<div class="content">

    <!-- CONTENT HEADER -->
    <div class="content-header">
        <ul class="content-header-meta">
            <li class="prefix-icon guideline">Guideline Summary</li>
            <li>NGC:009904</li>
            <li>2005 Oct (revised 2013 Apr)
            </li>            
                                </ul>
        <div>
                <h1>Attention-deficit hyperactivity disorder.</h1>
        </div>
    </div>
    <!-- /.content-header-meta -->

        <!-- CONTENT TABS -->
        <ul class="content-tabs">
            <li><a href="#developer-tab" class="developer is-active"><span class="label">Developer</span></a></li>
            <li><a href="#source-tab" class="source"><span class="label">Source</span></a></li>
            <li><a href="#status-tab" class="status"><span class="label">Status</span></a></li>
            <li><a href="#classification-tab" class="classification"><span class="label">Classification</span></a></li>
        </ul>
        <div id="developer-tab" class="is-active content-tab-panel">
                <ul class="developer-list">
        <li><a href="/web/20180712183206/https://www.guideline.gov/search?f_Guideline_Developer_String=University%20of%20Michigan%20Health%20System&amp;fLockTerm=University%2Bof%2BMichigan%2BHealth%2BSystem">University of Michigan Health System</a></li>
                        <li>   
                                <a id="988" href="#" data-alert="SignInLanding" data-alert-type="organization" class="get-alerts get-org-alerts">Get Alerts</a>
                        </li>
                </ul>
        </div>
    <!-- /.content-tab-panel -->
    <div id="source-tab" class="content-tab-panel">
<table><tr><td>University of Michigan Health System. Attention-deficit hyperactivity disorder. Ann Arbor (MI): University of Michigan Health System; 2013 Apr. 41 p.  [14 references]</td></tr></table>                    <p><a href="/web/20180712183206/https://www.guideline.gov/Home/Disclaimer?id=46415&amp;contentType=fulltextlink&amp;redirect=http%253a%252f%252fwww.med.umich.edu%252f1info%252ffhp%252fpracticeguides%252fadhd.html">View the original guideline documentation</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712183206im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/></p>
    </div>
    <!-- /.content-tab-panel -->
    <div id="status-tab" class="content-tab-panel">
            <p><div class="content_para"><p>This is the current release of the guideline.</p>
<p>This guideline updates a previous version: University of Michigan Health System. Attention-deficit hyperactivity disorder. Ann Arbor (MI): University of Michigan Health System; 2005 Oct. 35 p. [8 references]</p></div></p>
    </div>
    <!-- /.content-tab-panel -->
    <div id="classification-tab" class="content-tab-panel">


        
                    <h4>Age Group</h4>
            <ul>
                        <li><a href="/web/20180712183206/https://www.guideline.gov/search?f_Age_of_Target_Population=Adolescent%20%2813%20to%2018%20years%29&amp;fLockTerm=Adolescent%2B%2813%2Bto%2B18%2Byears%29">Adolescent (13 to 18 years)</a></li>                      
                        <li><a href="/web/20180712183206/https://www.guideline.gov/search?f_Age_of_Target_Population=Adult%20%2819%20to%2044%20years%29&amp;fLockTerm=Adult%2B%2819%2Bto%2B44%2Byears%29">Adult (19 to 44 years)</a></li>                      
                        <li><a href="/web/20180712183206/https://www.guideline.gov/search?f_Age_of_Target_Population=Child%20%282%20to%2012%20years%29&amp;fLockTerm=Child%2B%282%2Bto%2B12%2Byears%29">Child (2 to 12 years)</a></li>                      
            </ul>
                    <h4>UMLS Concepts <a href="/web/20180712183206/https://www.guideline.gov/help-and-about/search-browse/umls-concepts" class="what-is">(what is this?)</a></h4>
                <div class="field">
                    <h5 class="field-label">HCPCS</h5>
                    <div class="field-content">
<a href="/web/20180712183206/https://www.guideline.gov/search?f_HCPCS_CUI=C0025355&amp;fLockTerm=Mental+health+services%2c+not+otherwise+specified">Mental health services, not otherwise specified</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">ICD9CM</h5>
                    <div class="field-content">
<a href="/web/20180712183206/https://www.guideline.gov/search?f_ICD9CM_CUI=C0021705&amp;fLockTerm=Administration+of+intelligence+test">Administration of intelligence test</a>
 (94.01), <a href="/web/20180712183206/https://www.guideline.gov/search?f_ICD9CM_CUI=C1263846&amp;fLockTerm=Attention+deficit+disorder+with+hyperactivity">Attention deficit disorder with hyperactivity</a>
 (314.01), <a href="/web/20180712183206/https://www.guideline.gov/search?f_ICD9CM_CUI=C1263846&amp;fLockTerm=Attention+deficit+disorder+with+hyperactivity">Attention deficit disorder with hyperactivity</a>
 (314.9), <a href="/web/20180712183206/https://www.guideline.gov/search?f_ICD9CM_CUI=C0009818&amp;fLockTerm=Consultation%2c+not+otherwise+specified">Consultation, not otherwise specified</a>
 (89.09), <a href="/web/20180712183206/https://www.guideline.gov/search?f_ICD9CM_CUI=C0015618&amp;fLockTerm=Family+therapy">Family therapy</a>
 (94.42), <a href="/web/20180712183206/https://www.guideline.gov/search?f_ICD9CM_CUI=C0031809&amp;fLockTerm=General+physical+examination">General physical examination</a>
 (89.7), <a href="/web/20180712183206/https://www.guideline.gov/search?f_ICD9CM_CUI=C0027853&amp;fLockTerm=Neurologic+examination">Neurologic examination</a>
 (89.13)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MSH</h5>
                    <div class="field-content">
<a href="/web/20180712183206/https://www.guideline.gov/search?f_MSH_CUI=C0085100&amp;fLockTerm=Adolescent+Health+Services">Adolescent Health Services</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MSH_CUI=C0002667&amp;fLockTerm=Amphetamines">Amphetamines</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MSH_CUI=C0003364&amp;fLockTerm=Antihypertensive+Agents">Antihypertensive Agents</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MSH_CUI=C1263846&amp;fLockTerm=Attention+Deficit+Disorder+with+Hyperactivity">Attention Deficit Disorder with Hyperactivity</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MSH_CUI=C0085208&amp;fLockTerm=Bupropion">Bupropion</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MSH_CUI=C0002763&amp;fLockTerm=Central+Nervous+System+Stimulants">Central Nervous System Stimulants</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MSH_CUI=C0008079&amp;fLockTerm=Child+Health+Services">Child Health Services</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MSH_CUI=C0009014&amp;fLockTerm=Clonidine">Clonidine</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MSH_CUI=C0009244&amp;fLockTerm=Cognitive+Therapy">Cognitive Therapy</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MSH_CUI=C0009488&amp;fLockTerm=Comorbidity">Comorbidity</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MSH_CUI=C0936077&amp;fLockTerm=Complementary+Therapies">Complementary Therapies</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MSH_CUI=C0011685&amp;fLockTerm=Desipramine">Desipramine</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MSH_CUI=C0011812&amp;fLockTerm=Dextroamphetamine">Dextroamphetamine</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MSH_CUI=C1136324&amp;fLockTerm=Diagnostic+and+Statistical+Manual+of+Mental+Disorders">Diagnostic and Statistical Manual of Mental Disorders</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MSH_CUI=C0013649&amp;fLockTerm=Education%2c+Special">Education, Special</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MSH_CUI=C0015618&amp;fLockTerm=Family+Therapy">Family Therapy</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MSH_CUI=C0079466&amp;fLockTerm=Guanfacine">Guanfacine</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MSH_CUI=C0021705&amp;fLockTerm=Intelligence+Tests">Intelligence Tests</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MSH_CUI=C0025084&amp;fLockTerm=Medical+History+Taking">Medical History Taking</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MSH_CUI=C0025355&amp;fLockTerm=Mental+Health+Services">Mental Health Services</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MSH_CUI=C0025810&amp;fLockTerm=Methylphenidate">Methylphenidate</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MSH_CUI=C0027853&amp;fLockTerm=Neurologic+Examination">Neurologic Examination</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MSH_CUI=C0030688&amp;fLockTerm=Patient+Education+as+Topic">Patient Education as Topic</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MSH_CUI=C0031809&amp;fLockTerm=Physical+Examination">Physical Examination</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MSH_CUI=C0033871&amp;fLockTerm=Psychiatric+Status+Rating+Scales">Psychiatric Status Rating Scales</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MSH_CUI=C0034928&amp;fLockTerm=Referral+and+Consultation">Referral and Consultation</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MSH_CUI=C0073393&amp;fLockTerm=Risperidone">Risperidone</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MSH_CUI=C0036606&amp;fLockTerm=Self-Help+Groups">Self-Help Groups</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MTH</h5>
                    <div class="field-content">
<a href="/web/20180712183206/https://www.guideline.gov/search?f_MTH_CUI=C0795571&amp;fLockTerm=amphetamine-dextroamphetamine">amphetamine-dextroamphetamine</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MTH_CUI=C0002667&amp;fLockTerm=Amphetamines">Amphetamines</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MTH_CUI=C0003364&amp;fLockTerm=Antihypertensive+Agents">Antihypertensive Agents</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MTH_CUI=C0076823&amp;fLockTerm=atomoxetine">atomoxetine</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MTH_CUI=C1263846&amp;fLockTerm=Attention+deficit+hyperactivity+disorder">Attention deficit hyperactivity disorder</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MTH_CUI=C0085208&amp;fLockTerm=Bupropion">Bupropion</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MTH_CUI=C0002763&amp;fLockTerm=Central+Nervous+System+Stimulants">Central Nervous System Stimulants</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MTH_CUI=C0008079&amp;fLockTerm=Child+Health+Services">Child Health Services</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MTH_CUI=C0009244&amp;fLockTerm=Cognitive+Therapy">Cognitive Therapy</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MTH_CUI=C0936077&amp;fLockTerm=Complementary+therapies">Complementary therapies</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MTH_CUI=C0009818&amp;fLockTerm=Consultation">Consultation</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MTH_CUI=C0011685&amp;fLockTerm=Desipramine">Desipramine</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MTH_CUI=C1169997&amp;fLockTerm=dexmethylphenidate">dexmethylphenidate</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MTH_CUI=C0011812&amp;fLockTerm=Dextroamphetamine">Dextroamphetamine</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MTH_CUI=C0600015&amp;fLockTerm=Emotional+support">Emotional support</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MTH_CUI=C0015618&amp;fLockTerm=Family+psychotherapy">Family psychotherapy</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MTH_CUI=C0021705&amp;fLockTerm=Intelligence+Tests">Intelligence Tests</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MTH_CUI=C0025810&amp;fLockTerm=Methylphenidate">Methylphenidate</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MTH_CUI=C0027853&amp;fLockTerm=Neurologic+Examination">Neurologic Examination</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MTH_CUI=C0030688&amp;fLockTerm=Patient+education+(procedure)">Patient education (procedure)</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MTH_CUI=C0031809&amp;fLockTerm=physical+examination">physical examination</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MTH_CUI=C0559197&amp;fLockTerm=Skills+training">Skills training</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MTH_CUI=C0013649&amp;fLockTerm=Special+Education">Special Education</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_MTH_CUI=C0036606&amp;fLockTerm=Support+Groups">Support Groups</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">PDQ</h5>
                    <div class="field-content">
<a href="/web/20180712183206/https://www.guideline.gov/search?f_PDQ_CUI=C0009014&amp;fLockTerm=clonidine">clonidine</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_PDQ_CUI=C1169997&amp;fLockTerm=dexmethylphenidate">dexmethylphenidate</a>
, <a href="/web/20180712183206/https://www.guideline.gov/search?f_PDQ_CUI=C0795571&amp;fLockTerm=dextroamphetamine-amphetamine">dextroamphetamine-amphetamine</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">SNOMEDCT_US</h5>
                    <div class="field-content">
<a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0795571&amp;fLockTerm=Amfetamine+and+dexamfetamine">Amfetamine and dexamfetamine</a>
 (411098003), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0076823&amp;fLockTerm=Atomoxetine">Atomoxetine</a>
 (407037005), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0076823&amp;fLockTerm=Atomoxetine">Atomoxetine</a>
 (407038000), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1263846&amp;fLockTerm=Attention+deficit+hyperactivity+disorder">Attention deficit hyperactivity disorder</a>
 (406506008), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1263846&amp;fLockTerm=Attention+deficit+hyperactivity+disorder">Attention deficit hyperactivity disorder</a>
 (7461003), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0085208&amp;fLockTerm=Bupropion">Bupropion</a>
 (387564004), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0085208&amp;fLockTerm=Bupropion">Bupropion</a>
 (96199001), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0002763&amp;fLockTerm=Central+stimulant">Central stimulant</a>
 (349897000), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0002763&amp;fLockTerm=Central+stimulant">Central stimulant</a>
 (372620004), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0009014&amp;fLockTerm=Clonidine">Clonidine</a>
 (372805007), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0009014&amp;fLockTerm=Clonidine">Clonidine</a>
 (62782004), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0009244&amp;fLockTerm=Cognitive+therapy">Cognitive therapy</a>
 (183383008), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0009244&amp;fLockTerm=Cognitive+therapy">Cognitive therapy</a>
 (228553007), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0009244&amp;fLockTerm=Cognitive+therapy">Cognitive therapy</a>
 (228557008), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0009244&amp;fLockTerm=Cognitive+therapy">Cognitive therapy</a>
 (304891004), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0936077&amp;fLockTerm=Complementary+therapy">Complementary therapy</a>
 (225423004), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0009818&amp;fLockTerm=Consultation">Consultation</a>
 (11429006), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0009818&amp;fLockTerm=Consultation">Consultation</a>
 (223475005), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0011685&amp;fLockTerm=Desipramine">Desipramine</a>
 (33378002), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0011685&amp;fLockTerm=Desipramine">Desipramine</a>
 (372705002), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1169997&amp;fLockTerm=Dexmethylphenidate">Dexmethylphenidate</a>
 (385551001), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0011812&amp;fLockTerm=Dextroamphetamine">Dextroamphetamine</a>
 (387278002), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0011812&amp;fLockTerm=Dextroamphetamine">Dextroamphetamine</a>
 (50868004), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0600015&amp;fLockTerm=Emotional+support">Emotional support</a>
 (133921002), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0015618&amp;fLockTerm=Family+psychotherapy+procedure">Family psychotherapy procedure</a>
 (108313002), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0015618&amp;fLockTerm=Family+psychotherapy+procedure">Family psychotherapy procedure</a>
 (51484002), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0079466&amp;fLockTerm=Guanfacine">Guanfacine</a>
 (108553003), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0079466&amp;fLockTerm=Guanfacine">Guanfacine</a>
 (372507007), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0003364&amp;fLockTerm=Hypotensive+agent">Hypotensive agent</a>
 (1182007), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0003364&amp;fLockTerm=Hypotensive+agent">Hypotensive agent</a>
 (372586001), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0021705&amp;fLockTerm=Intelligence+test">Intelligence test</a>
 (72657008), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1873633&amp;fLockTerm=Lisdexamfetamine">Lisdexamfetamine</a>
 (425597005), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C1873633&amp;fLockTerm=Lisdexamfetamine">Lisdexamfetamine</a>
 (426249000), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0025355&amp;fLockTerm=Mental+health+service">Mental health service</a>
 (708168004), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0025810&amp;fLockTerm=Methylphenidate">Methylphenidate</a>
 (18548003), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0025810&amp;fLockTerm=Methylphenidate">Methylphenidate</a>
 (373337007), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0027853&amp;fLockTerm=Neurological+assessment">Neurological assessment</a>
 (225398001), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0027853&amp;fLockTerm=Neurological+assessment">Neurological assessment</a>
 (84728005), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0150295&amp;fLockTerm=Parent+education%3a+adolescent">Parent education: adolescent</a>
 (386380002), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0150297&amp;fLockTerm=Parent+education%3a+childrearing+family">Parent education: childrearing family</a>
 (386381003), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0030688&amp;fLockTerm=Patient+education">Patient education</a>
 (311401005), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0031809&amp;fLockTerm=Physical+examination">Physical examination</a>
 (302199004), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0031809&amp;fLockTerm=Physical+examination">Physical examination</a>
 (5880005), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0031809&amp;fLockTerm=Physical+examination">Physical examination</a>
 (81375008), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0204452&amp;fLockTerm=Psychological+assessment">Psychological assessment</a>
 (405783006), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0204452&amp;fLockTerm=Psychological+assessment">Psychological assessment</a>
 (45392008), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0073393&amp;fLockTerm=Risperidone">Risperidone</a>
 (108386000), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0073393&amp;fLockTerm=Risperidone">Risperidone</a>
 (386840002), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0559197&amp;fLockTerm=Skills+training">Skills training</a>
 (278445004), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0150777&amp;fLockTerm=Social+skills+training">Social skills training</a>
 (228559006), <a href="/web/20180712183206/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0036606&amp;fLockTerm=Support+groups">Support groups</a>
 (224879000)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
    </div>
        <!-- /.content-tab-panel -->
        <!-- /.content-tab-panel -->
        <!-- TOOLBAR -->
        <div class="content-toolbar">

            <!-- Primary -->
            <ul class="tools primary-tools">
                <li class="dropdown tool sections">
                    <a href="#" class="tool-button">Sections</a>
                    <div class="dropdown-panel">
                            <ul class="section-links">
                                    <li><a href="#420" class="section-mark">Recommendations</a></li>
                                    <li><a href="#396" class="section-mark">Scope</a></li>
                                    <li><a href="#405" class="section-mark">Methodology</a></li>
                                    <li><a href="#424" class="section-mark">Evidence Supporting the Recommendations</a></li>
                                    <li><a href="#427" class="section-mark">Benefits/Harms of Implementing the Guideline Recommendations</a></li>
                                    <li><a href="#430" class="section-mark">Contraindications</a></li>
                                    <li><a href="#432" class="section-mark">Qualifying Statements</a></li>
                                    <li><a href="#434" class="section-mark">Implementation of the Guideline</a></li>
                                    <li><a href="#439" class="section-mark">Institute of Medicine (IOM) National Healthcare Quality Report Categories</a></li>
                                    <li><a href="#442" class="section-mark">Identifying Information and Availability</a></li>
                                    <li><a href="#99999" class="section-mark">Disclaimer</a></li>
                            </ul>    
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
            </ul>

            <!-- Other -->
            <ul class="tools other-tools">
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Download</a>

                    <div class="dropdown-panel">
                        <ul>
                            <li><a href="/web/20180712183206/https://www.guideline.gov/summaries/downloadcontent/ngc-9904?contentType=pdf" class="pdf">.PDF 97.0 kb</a></li>
                            <li><a href="/web/20180712183206/https://www.guideline.gov/summaries/downloadcontent/ngc-9904?contentType=word" class="word">Word Document 289.8 kb</a></li>
                            <li><a href="/web/20180712183206/https://www.guideline.gov/summaries/downloadcontent/ngc-9904?contentType=xml" class="xml">.XML 38.2 kb</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Share</a>
                    <div class="dropdown-panel">
                        <ul class="toolbar-social">
                            <li><a target="_blank" href="https://web.archive.org/web/20180712183206/https://www.facebook.com/sharer/sharer.php?u=https://www.guideline.gov/summaries/summary/46415/attentiondeficit-hyperactivity-disorder" class="facebook">Facebook</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180712183206/https://twitter.com/share?text=&amp;url=https://www.guideline.gov/summaries/summary/46415/attentiondeficit-hyperactivity-disorder" class="twitter">Twitter</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180712183206/https://www.linkedin.com/shareArticle?mini=true&amp;url=https://www.guideline.gov/summaries/summary/46415/attentiondeficit-hyperactivity-disorder&amp;title=&amp;summary=&amp;source=" class="linkedin">Linkedin</a></li>
                            <li><a href="https://web.archive.org/web/20180712183206/mailto:/?Subject=AHRQ: Attention-deficit hyperactivity disorder.&amp;body=https://www.guideline.gov/summaries/summary/46415/attentiondeficit-hyperactivity-disorder" class="email">Email</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Cite</a>
                    <div class="dropdown-panel citation">
                        <p class="text-label"><label for="citation">Citation: </label></p>
                        <textarea id="citation">National Guideline Clearinghouse (NGC). Guideline summary: Attention-deficit hyperactivity disorder. In: National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2013 Apr 01. [cited 2018 Jul 12]. Available: https://www.guideline.gov</textarea>                        
                        <p class="text-label">Download citation file: </p>
                        <ul>
                            <li><a href="/web/20180712183206/https://www.guideline.gov/summaries/citedownload/46415?format=ris">RIS (Zotero)</a></li>
                            <li><a href="/web/20180712183206/https://www.guideline.gov/summaries/citedownload/46415?format=enw">EndNote</a></li>
                            <li><a href="/web/20180712183206/https://www.guideline.gov/summaries/citedownload/46415?format=bibtex">BibTex</a></li>
                            <li><a href="/web/20180712183206/https://www.guideline.gov/summaries/citedownload/46415?format=txt">Medlars</a></li>
                            <li><a href="/web/20180712183206/https://www.guideline.gov/summaries/citedownload/46415?format=ris">ProCite</a></li>
                            <li><a href="/web/20180712183206/https://www.guideline.gov/summaries/citedownload/46415">RefWorks</a></li>
                            <li><a href="/web/20180712183206/https://www.guideline.gov/summaries/citedownload/46415?format=ris">Reference Manager</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                                
                <li class="tool">
                        <a href="#" id="46415" data-alert="SignInLanding" class="tool-button save-link">Save</a>
                </li>
            </ul>

            <!-- Accordion -->
            <ul class="tools accordion-controls">
                <li class="tool"><a href="#" class="expand-all is-disabled" aria-disabled="true"><span class="screen-reader-text">Expand All</span></a></li>
                <li class="tool"><a href="#" class="collapse-all" aria-disabled="false"><span class="screen-reader-text">Collapse All</span></a></li>
            </ul>
        </div>
        <!-- /.toolbar -->


		<!-- ARTICLE -->
		<div class="article" id="article">
			




    <!-- ACCORDION -->
    <div class="accordion-container" role="tablist" multiselectable="true">
                <h2 id="420" class="accordion-title section-420 is-active" role="tab" aria-expanded="true"><a href="#">Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Major Recommendations</a></h3>
                    <p><div class="content_para"><p><strong><em>Note from the University of Michigan Health System (UMHS) and the National Guideline Clearinghouse (NGC)</em></strong>: The following guidance was current as of April 2013. Because UMHS occasionally releases minor revisions to its guidance based on new information, users may wish to consult the <a href="/web/20180712183206/https://www.guideline.gov/Home/Disclaimer?id=46415&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.med.umich.edu%2f1info%2ffhp%2fpracticeguides%2fadhd%2fadhd.pdf" title="UMHS Web site">original guideline document</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712183206im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/> or the most current version.</p>
<p>The strength of recommendation (I-III) and levels of evidence (A-D) are defined at the end of the "Major Recommendations" field.</p>
<p><strong><span style="text-decoration: underline;">Key Points</span></strong></p>
<p><strong>Epidemiology</strong></p>
<p><em>Common</em></p>
<p>Attention-deficit hyperactivity disorder (ADHD) is the most common behavioral disorder in school-age children &ndash; a U.S. community prevalence of 6-8% that is more common in boys <strong>[<em>C</em>]</strong>. In at least 30% of diagnosed children ADHD continues into adulthood, with 3-4% of adults meeting criteria for ADHD <strong>[<em>C</em>]</strong>.</p>
<p><em>Primary Care Provider</em></p>
<p>Most children with ADHD receive care through primary care physicians.</p>
<p><strong>Diagnosis</strong></p>
<p><em>Types</em></p>
<p>Diagnosis is based on the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV-TR) criteria (see Table 1 in the original guideline document) <strong>[<em>D</em>]</strong>. The three main types are primary hyperactive, primary inattentive, and combined.</p>
<p><em>Multiple Sources</em></p>
<p>No specific test can make the diagnosis. Input from both parents and teachers or other source is required. Some psychological rating tools are useful but are not diagnostic (e.g., Vanderbilt, Conners; see Figure 1, Tables 1 &amp; 2, and Appendix A1 in the original guideline document). If a learning problem is suspected, consider neuropsychiatric testing for intelligence testing (IQ) and learning disorders.</p>
<p><em>Confused and Associated Conditions</em></p>
<p>Diagnosis is complicated by overlapping symptoms or co-occurrence of other disorders (e.g., anxiety disorders, bipolar disorder, obstructive sleep apnea, fetal alcohol syndrome, major depressive disorders, learning disorders, oppositional defiant disorder, post traumatic stress disorder, reactive attachment disorder; see Appendices B1 &amp; B2 in the original guideline document).</p>
<p><strong>Treatment</strong> (See Table 4 in the original guideline document)</p>
<p><em>Drug Treatment</em></p>
<ul style="list-style-type: disc;">
    <li>Stimulants are the first line treatment and have proven benefit to most people. If one class of stimulant fails or has unacceptable side effects then another should be tried (Tables 5-7 in the original guideline document) <strong>[<em>IA</em>]</strong>. </li>
    <li>Atomoxetine is a secondary choice <strong>[<em>IA</em>]</strong>. (One reported side effect is suicidal thinking.) </li>
    <li>Other medications may be used alone or in combination depending upon the ADHD type, response to therapy or comorbidity profile: e.g., Alpha-II agonists (clonidine, guanfacine) with hyperactivity or impulsivity; bupropion (over age 8) with co-morbid depression; risperidone (atypical antipsychotic) for aggression (see Table 7 in the original guideline document) <strong>[<em>IIA</em>]</strong>. </li>
    <li>Comorbid conditions may require additional treatment (e.g., for depression) and consideration of referral to a mental health specialist. </li>
</ul>
<p><em>Non-Pharmacologic Interventions</em></p>
<ul style="list-style-type: disc;">
    <li>Age-appropriate behavioral interventions at home: education and support <strong>[<em>IB</em>]</strong>; parent interventions including routines, clear limits and positive reinforcement for target behaviors (for children); consider family therapy; cognitive behavioral techniques for adults <strong>[<em>IIB</em>]</strong> (see Table 8 and Appendix A2 in the original guideline document). </li>
    <li>School interventions: children with ADHD may qualify for a 504 education plan or special education services with individualized education plan (IEP) <strong>[<em>ID</em>]</strong> (see Appendices A3 &amp; A4 in the original guideline document). </li>
</ul>
<p><strong>Special Populations or Circumstances</strong></p>
<p>Special considerations apply to: 3-5 year olds, adolescents and adults, head-injured, intellectually disabled/autistic, fetal alcohol syndrome, and substance-abusing patients (see Appendix B3 in the original guideline document).</p>
<p><strong>Controversial Areas</strong></p>
<p><em>Common Myths</em></p>
<p>Several common beliefs related to ADHD are untrue, e.g., that it is not a real disorder, it is an over-diagnosed disorder, children with ADHD are over-medicated.</p>
<p><em>Diets</em></p>
<p>Although a few studies suggest dietary modification may have promise, there is no proof of efficacy (e.g., individually tailored hypoallergenic diets, essential fatty acids, flax seed) <strong>[<em>IIB</em>]</strong>, studies have shown the Feingold diet and modifying sugar consumption have no effect <strong>[<em>IIIB</em>]</strong>.</p>
<p><em>Complementary Alternative Medicine</em></p>
<p>Use is controversial, but common (see Appendix B4 in the original guideline document).</p>
<p><strong><span style="text-decoration: underline;">Definitions</span></strong>:</p>
<p><strong>Levels of Evidence Supporting a Diagnostic Method or an Intervention</strong></p>
<ol style="list-style-type: upper-alpha;">
    <li>Randomized controlled trials </li>
    <li>Controlled trials, no randomization </li>
    <li>Observational trials </li>
    <li>Opinion of expert panel </li>
</ol>
<p><strong>Strength of Recommendation</strong></p>
<ol style="list-style-type: upper-roman;">
    <li>Generally should be performed </li>
    <li>May be reasonable to perform </li>
    <li>Generally should not be performed </li>
</ol></div></p>
                        <h3><a href="#">Clinical Algorithm(s)</a></h3>
                    <p><div class="content_para"><p>An algorithm is provided in the original guideline document for the diagnosis and treatment of the child age 4-18 years with attention-deficit hyperactivity disorder (ADHD).</p></div></p>

            </div>
                <h2 id="396" class="accordion-title section-396 is-active" role="tab" aria-expanded="true"><a href="#">Scope</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Disease/Condition(s)</a></h3>
                    <p><div class="content_para"><p>Attention-deficit hyperactivity disorder (ADHD)</p></div></p>
                        <h3><a href="#">Guideline Category</a></h3>
                    <p>Diagnosis</p>
                    <p>Evaluation</p>
                    <p>Management</p>
                    <p>Treatment</p>
                        <h3><a href="#">Clinical Specialty</a></h3>
                    <p>Family Practice</p>
                    <p>Internal Medicine</p>
                    <p>Pediatrics</p>
                    <p>Psychology</p>
                        <h3><a href="#">Intended Users</a></h3>
                    <p>Advanced Practice Nurses</p>
                    <p>Nurses</p>
                    <p>Physician Assistants</p>
                    <p>Physicians</p>
                    <p>Psychologists/Non-physician Behavioral Health Clinicians</p>
                        <h3><a href="#">Guideline Objective(s)</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>To recognize and treat attention-deficit hyperactivity disorder (ADHD) early in the primary care setting </li>
    <li>To identify appropriate treatment options and drug side effects </li>
    <li>To identify common co-morbidities and indications for referral </li>
    <li>To identify appropriate support resources for patients and their families </li>
</ul></p>
                        <h3><a href="#">Target Population</a></h3>
                    <p><div class="content_para"><p>Children and young adults age 3 to 30 years</p>
<p class="Note"><strong>Note</strong>: Considerations for preschool children (3-5) and adults (18-30) are discussed as "Special Populations."</p></div></p>
                        <h3><a href="#">Interventions and Practices Considered</a></h3>
                    <p><div class="content_para"><p><strong>Assessment/Diagnosis</strong></p>
<ol style="list-style-type: decimal;" start="1">
    <li>Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV-TR) criteria to establish diagnosis </li>
    <li>Input from multiple sources (parents, teachers, others) </li>
    <li>Assessment for coexisting conditions </li>
</ol>
<p><strong>Management/Treatment</strong></p>
<ol style="list-style-type: decimal;" start="1">
    <li>Pharmacologic therapy
    <ul style="list-style-type: disc;">
        <li>Stimulants (methylphenidate, dexmethylphenidate, mixed amphetamine salts, dextroamphetamine, lisdexamfetamine) </li>
        <li>Non-stimulants (atomoxetine) </li>
        <li>Alpha-II agonists (clonidine, guanfacine) </li>
        <li>Bupropion </li>
        <li>Risperidone </li>
    </ul>
    </li>
    <li>Referral to mental health professional </li>
    <li>Non-pharmacologic therapy
    <ul style="list-style-type: disc;">
        <li>Age-appropriate behavioral interventions at home (education and support, parent interventions including routines, clear limits and positive reinforcement for target behaviors for children, family therapy, cognitive behavioral techniques for adults) </li>
        <li>School interventions (504 education plan or special education services with individualized education plan) </li>
    </ul>
    </li>
    <li>Special considerations for specific populations (3-5 year olds, adolescents and adults, head-injured, intellectually disabled/autistic, fetal alcohol syndrome, and substance-abusing patients) </li>
</ol></div></p>
                        <h3><a href="#">Major Outcomes Considered</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>Incidence of comorbid disorders </li>
    <li>Adverse effects of drug therapy </li>
    <li>Response to therapy </li>
    <li>Academic performance</li>
    <li>Symptom control</li>
    <li>Incidence of substance abuse disorders</li>
</ul></p>

            </div>
                <h2 id="405" class="accordion-title section-405 is-active" role="tab" aria-expanded="true"><a href="#">Methodology</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Methods Used to Collect/Select the Evidence</a></h3>
                    <p>Hand-searches of Published Literature (Primary Sources)</p>
                    <p>Hand-searches of Published Literature (Secondary Sources)</p>
                    <p>Searches of Electronic Databases</p>
                    <p>Searches of Unpublished Data</p>
                        <h3><a href="#">Description of Methods Used to Collect/Select the Evidence</a></h3>
                    <p><div class="content_para"><p>The literature search for this update began with results of the literature search performed in 2002 to develop the initial guideline released in 2005. The literature search for this update used keywords that were very similar to those used in the previous search. However, instead of beginning the search with literature in 2002, the guideline team accepted the search strategy and results for the search performed through April 2006 for the American Academy of Child &amp; Adolescent Psychiatry (AACAP) Practice Parameter for the Assessment and Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD).</p>
<p>The search for this update was conducted prospectively using the major keywords of: attention deficit disorder with hyperactivity, humans age 3-30, clinical guidelines, controlled clinical trials, cohort studies, English language, and published 1/1/07-1/1/10 on Medline. Additional key words for specific searches included: symptoms (academic underachievement, behavior problems, classroom behavior, classroom interventions, degree of functional impairment, evidence of school work, frequent disciplinary events, hyperactivity, impulsivity, inattention, learning patterns, poor concentration, poor task completion, social adjustment), commonly associated/coexisting conditions (learning/language disorder, child abuse, medication side effects, oppositional defiant disorder, conduct disorder, anxiety, depression), commonly confused conditions/differential diagnosis (learning disorder, intellectual disability, mood/anxiety disorder, abuse, developmental delay, static encephalopathy, pervasive development disorder, autism spectrum, absence seizures, sleep disorder, substance abuse) evaluation and testing (vision exam, hearing exam, growth chart, developmental review, neurological exam, chronic physical or mental disorders), rating scales for ADHD, qualitative electroencephalogram (EEG) and functional magnetic resonance imaging (MRI), other EEG, cognitive behavioral therapy, behavioral interventions (set limits, establish routines, provide positive reinforcement), parental intervention (parenting class, family therapy), alpha-II agonists (clonidine, tenex), antidepressants &ndash; wellbutrin, effexor, tricyclics (imipramine, nortriptyline, desipramine), stimulants (adderall, concerta, daytrana, dexedrine, dextroamphetamine, focalin, metadate, methylphenidate, ritalin, vyvanse), modafanil, strattera, transitional and longitudinal care for adults (since 10/1/02), and nutritional supplements and diet (since 10/1/02).</p>
<p>The search was conducted in components each keyed to a specific causal link in a formal problem structure (available upon request). The search was supplemented with very recent clinical trials known to expert members of the panel. Negative trials were specifically sought. The search was a single cycle.</p></div></p>
                        <h3><a href="#">Number of Source Documents</a></h3>
                    <p><div class="content_para"><p>Not stated</p></div></p>
                        <h3><a href="#">Methods Used to Assess the Quality and Strength of the Evidence</a></h3>
                    <p>Weighting According to a Rating Scheme (Scheme Given)</p>
                        <h3><a href="#">Rating Scheme for the Strength of the Evidence</a></h3>
                    <p><div class="content_para"><p><strong>Levels of Evidence Supporting a Diagnostic Method or an Intervention</strong></p>
<ol style="list-style-type: upper-alpha;" start="1">
    <li>Randomized controlled trials </li>
    <li>Controlled trials, no randomization </li>
    <li>Observational trials </li>
    <li>Opinion of expert panel </li>
</ol></div></p>
                        <h3><a href="#">Methods Used to Analyze the Evidence</a></h3>
                    <p>Systematic Review</p>
                        <h3><a href="#">Description of the Methods Used to Analyze the Evidence</a></h3>
                    <p><div class="content_para"><p>Not stated</p></div></p>
                        <h3><a href="#">Methods Used to Formulate the Recommendations</a></h3>
                    <p>Expert Consensus</p>
                        <h3><a href="#">Description of Methods Used to Formulate the Recommendations</a></h3>
                    <p><div class="content_para"><p>Conclusions were based on prospective randomized controlled trials if available, to the exclusion of other data; if randomized controlled trials were not available, observational studies were admitted to consideration. If no such data were available for a given link in the problem formulation, expert opinion was used to estimate effect size.</p></div></p>
                        <h3><a href="#">Rating Scheme for the Strength of the Recommendations</a></h3>
                    <p><div class="content_para"><p><strong>Strength of Recommendation</strong></p>
<ol style="list-style-type: upper-roman;">
    <li>Generally should be performed </li>
    <li>May be reasonable to perform </li>
    <li>Generally should not be performed </li>
</ol></div></p>
                        <h3><a href="#">Cost Analysis</a></h3>
                    <p><div class="content_para"><p>Tables 5 &ndash; 8 in the original guideline document provides an overview of dosing, cost, side effects and other information for first line and second line agents for treatment of attention-deficit hyperactivity disorder (ADHD), respectively.</p></div></p>
                        <h3><a href="#">Method of Guideline Validation</a></h3>
                    <p>Comparison with Guidelines from Other Groups</p>
                    <p>External Peer Review</p>
                    <p>Internal Peer Review</p>
                        <h3><a href="#">Description of Method of Guideline Validation</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>Drafts of this guideline were reviewed in clinical conferences and by distribution for comment within departments and divisions of the University of Michigan Medical School to which the content is most relevant: Child and Behavioral Health, Family Medicine, General Pediatrics, and Child and Adolescent Psychiatry. The Executive Committee for Clinical Affairs of the University of Michigan Hospitals and Health Centers endorsed the final version. </li>
    <li>The University of Michigan Health System (UMHS) Clinical Guideline on attention deficit hyperactivity disorder (ADHD) is consistent with:
    <ul style="list-style-type: disc;">
        <li>American Academy of Child and Adolescent Psychiatry &ndash; Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder, 2007 </li>
        <li>American Academy of Pediatrics &ndash; ADHD: Clinical practice guideline for the diagnosis, evaluation, and treatment of Attention-Deficit/Hyperactivity Disorder in children and adolescents, 2011 </li>
    </ul>
    </li>
</ul></p>

            </div>
                <h2 id="424" class="accordion-title section-424 is-active" role="tab" aria-expanded="true"><a href="#">Evidence Supporting the Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Type of Evidence Supporting the Recommendations</a></h3>
                    <p><div class="content_para"><p>The type of supporting evidence is identified and graded for each recommendation (see the "Major Recommendations" field).</p>
<p>Conclusions were based on prospective randomized controlled trials if available, to the exclusion of other data; if randomized controlled trials were not available, observational studies were admitted to consideration. If no such data were available for a given link in the problem formulation, expert opinion was used to estimate effect size.</p></div></p>

            </div>
                <h2 id="427" class="accordion-title section-427 is-active" role="tab" aria-expanded="true"><a href="#">Benefits/Harms of Implementing the Guideline Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Potential Benefits</a></h3>
                    <p><div class="content_para"><p>Appropriate diagnosis and management of patients with attention-deficit hyperactivity disorder (ADHD)</p></div></p>
                        <h3><a href="#">Potential Harms</a></h3>
                    <p><div class="content_para"><p>Adverse effects of stimulants and non-stimulants used in treatment of attention-deficit hyperactivity disorder (ADHD) are listed in Table 6 in the original guideline document. Drug class side effects for second-line drugs are listed in Table 7 in the original guideline document.</p></div></p>

            </div>
                <h2 id="430" class="accordion-title section-430 is-active" role="tab" aria-expanded="true"><a href="#">Contraindications</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Contraindications</a></h3>
                    <p><div class="content_para"><p>Bupropion is contraindicated in patients who have bulimia or anorexia nervosa.</p></div></p>

            </div>
                <h2 id="432" class="accordion-title section-432 is-active" role="tab" aria-expanded="true"><a href="#">Qualifying Statements</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Qualifying Statements</a></h3>
                    <p><div class="content_para"><p>These guidelines should not be construed as including all proper methods of care or excluding other acceptable methods of care reasonably directed to obtaining the same results. The ultimate judgment regarding any specific clinical procedure or treatment must be made by the physician in light of the circumstances presented by the patient.</p></div></p>

            </div>
                <h2 id="434" class="accordion-title section-434 is-active" role="tab" aria-expanded="true"><a href="#">Implementation of the Guideline</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Description of Implementation Strategy</a></h3>
                    <p><div class="content_para"><p>An implementation strategy was not provided.</p></div></p>
                        <h3><a href="#">Implementation Tools</a></h3>
                    <p>Clinical Algorithm</p>
                    <p>Patient Resources</p>
                    <p>Resources</p>
                    <p>Staff Training/Competency Material</p>
                    <p><div class="general-block">For information about availability, see the <i>Availability of Companion Documents</i> and <i>Patient Resources</i> fields below.</div></p>

            </div>
                <h2 id="439" class="accordion-title section-439 is-active" role="tab" aria-expanded="true"><a href="#">Institute of Medicine (IOM) National Healthcare Quality Report Categories</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">IOM Care Need</a></h3>
                    <p>Living with Illness</p>
                        <h3><a href="#">IOM Domain</a></h3>
                    <p>Effectiveness</p>
                    <p>Patient-centeredness</p>

            </div>
                <h2 id="442" class="accordion-title section-442 is-active" role="tab" aria-expanded="true"><a href="#">Identifying Information and Availability</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Bibliographic Source(s)</a></h3>
                    <p><table><tr><td>University of Michigan Health System. Attention-deficit hyperactivity disorder. Ann Arbor (MI): University of Michigan Health System; 2013 Apr. 41 p.  [14 references]</td></tr></table></p>
                        <h3><a href="#">Adaptation</a></h3>
                    <p><div class="content_para"><p>Not applicable: The guideline was not adapted from another source.</p></div></p>
                        <h3><a href="#">Date Released</a></h3>
                    <p>2005 Oct (revised 2013 Apr)</p>
                        <h3><a href="#">Guideline Developer(s)</a></h3>
                    <p>University of Michigan Health System - Academic Institution</p>
                        <h3><a href="#">Source(s) of Funding</a></h3>
                    <p><div class="content_para"><p>University of Michigan Health System (UMHS)</p></div></p>
                        <h3><a href="#">Guideline Committee</a></h3>
                    <p><div class="content_para"><p>Attention-Deficit Hyperactivity Disorder (ADHD) Guideline Team</p></div></p>
                        <h3><a href="#">Composition of Group That Authored the Guideline</a></h3>
                    <p><div class="content_para"><p><em>Team Leaders</em>: John M O'Brien, MD, Family Medicine; Jennifer G Christner, MD, Child Behavioral Health</p>
<p><em>Team Members</em>: Bernard Biermann, MD, PhD, Child/ Adolescent Psychiatry; Barbara T Felt, MD, Child Behavioral Health; R Van Harrison, PhD, Medical Education; Paramjeet K Kochhar, MD, General Pediatrics</p>
<p><em>Consultant</em>: Darcie-Ann Streetman, PharmD, College of Pharmacy</p>
<p><em>Guidelines Oversight Team</em>: Grant M Greenberg, MD, MA, MHSA; R Van Harrison, PhD</p></div></p>
                        <h3><a href="#">Financial Disclosures/Conflicts of Interest</a></h3>
                    <p><div class="content_para"><p>The University of Michigan Health System endorses the Guidelines of the Association of American Medical Colleges and the Standards of the Accreditation Council for Continuing Medical Education that the individuals who present educational activities disclose significant relationships with commercial companies whose products or services are discussed. Disclosure of a relationship is not intended to suggest bias in the information presented, but is made to provide readers with information that might be of potential importance to their evaluation of the information. No member of the guideline team (Drs. O'Brien, Christner, Biermann, Felt, Harrison, and Kochhar) nor the consultant (Dr. Streetman) has such a relationship.</p></div></p>
                        <h3><a href="#">Guideline Status</a></h3>
                    <p><div class="content_para"><p>This is the current release of the guideline.</p>
<p>This guideline updates a previous version: University of Michigan Health System. Attention-deficit hyperactivity disorder. Ann Arbor (MI): University of Michigan Health System; 2005 Oct. 35 p. [8 references]</p></div></p>
                        <h3><a href="#">Guideline Availability</a></h3>
                    <p><div class="content_para"><p>Electronic copies: Available from the <a href="/web/20180712183206/https://www.guideline.gov/Home/Disclaimer?id=46415&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.med.umich.edu%2f1info%2ffhp%2fpracticeguides%2fadhd.html" title="University of Michigan Health System (UMHS) Web site">University of Michigan Health System (UMHS) Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712183206im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>.</p></div></p>
                        <h3><a href="#">Availability of Companion Documents</a></h3>
                    <p><div class="content_para"><p>The following are available:</p>
<ul style="list-style-type: disc;">
    <li>Attention-Deficit Hyperactivity Disorder (ADHD). What's new - cover memo. Ann Arbor (MI): University of Michigan Health System; 2013 Apr. 2 p. Electronic copies: Available in Portable Document Format (PDF) from the <a href="/web/20180712183206/https://www.guideline.gov/Home/Disclaimer?id=46415&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.med.umich.edu%2f1info%2ffhp%2fpracticeguides%2fadhd%2fcover.pdf" title="University of Michigan Health System (UMHS) Web site">University of Michigan Health System (UMHS) Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712183206im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>Continuing Medical Education (CME) information is available from the <a href="/web/20180712183206/https://www.guideline.gov/Home/Disclaimer?id=46415&amp;contentType=summary&amp;redirect=http%3a%2f%2focpd.med.umich.edu%2fcme%2fself-study%2fAttention-Deficit%2520Hyperactivity%2520Disorder" title="University of Michigan Health System (UMHS) Web site">UMHS Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712183206im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
</ul>
<p>In addition, the following tools for clinicians can be found in the <a href="/web/20180712183206/https://www.guideline.gov/Home/Disclaimer?id=46415&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.med.umich.edu%2f1info%2ffhp%2fpracticeguides%2fadhd%2fadhd.pdf" title="University of Michigan Health System (UMHS) Web site">original guideline document </a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712183206im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>:</p>
<ul style="list-style-type: disc;">
    <li>Appendix A1. Behavioral Rating Scales </li>
    <li>Appendix A2. Tips for Parents </li>
    <li>Appendix A3. ADHD and Educational Rights </li>
    <li>Appendix A4. Special Education and Evaluation Terms </li>
    <li>Appendix B1. Definitions of Selected Psychiatric Disorders </li>
    <li>Appendix B2. Conditions That May Be Confused with ADHD </li>
    <li>Appendix B3. Special Patient Populations </li>
    <li>Appendix B4. Overview of complimentary/alternative medicine (CAM) </li>
</ul></div></p>
                        <h3><a href="#">Patient Resources</a></h3>
                    <p><div class="content_para"><p>The following is available:</p>
<ul style="list-style-type: disc;">
    <li>ADHD: what parents need to know. University of Michigan Health System; 2009 Jul. Various p. Electronic copies: Available from the <a href="/web/20180712183206/https://www.guideline.gov/Home/Disclaimer?id=46415&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.med.umich.edu%2fyourchild%2ftopics%2fadhd.htm" title="University of Michigan Health System (UMHS) Web site">University of Michigan Health System (UMHS) Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712183206im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
</ul>
<p class="Disclaimer">Please note: This patient information is intended to provide health professionals with information to share with their patients to help them better understand their health and their diagnosed disorders. By providing access to this patient information, it is not the intention of NGC to provide specific medical advice for particular patients. Rather we urge patients and their representatives to review this material and then to consult with a licensed health professional for evaluation of treatment options suitable for them as well as for diagnosis and answers to their personal medical questions. This patient information has been derived and prepared from a guideline for health care professionals included on NGC by the authors or publishers of that original guideline. The patient information is not reviewed by NGC to establish whether or not it accurately reflects the original guideline's content.</p></div></p>
                        <h3><a href="#">NGC Status</a></h3>
                    <p><div class="content_para"><p>This summary was completed by ECRI on December 8, 2005. The information was verified by the guideline developer on January 24, 2006. This summary was updated by ECRI on August 28, 2006 following the updated U.S. Food and Drug Administration advisory on Adderall. This summary was updated by ECRI on September 7, 2006 following the updated U.S. Food and Drug Administration advisory on Dexedrine. This summary was updated by ECRI Institute on November 9, 2007, following the U.S. Food and Drug Administration advisory on Antidepressant drugs. This summary was updated by ECRI Institute on July 20, 2009 following the U.S. Food and Drug Administration advisory on Varenicline and Bupropion. This summary was updated by ECRI Institute on January 8, 2010 following the U.S. Food and Drug Administration advisory on Norpramin. This NGC summary was updated by ECRI Institute on July 31, 2013. This summary was updated by ECRI Institute on April 7, 2014 following the U.S. Food and Drug Administration advisory on Methylphenidate ADHD Medications. This summary was updated by ECRI Institute on July 23, 2015 following the U.S. Food and Drug Administration advisory on the Daytrana Patch (methylphenidate transdermal system).</p></div></p>
                        <h3><a href="#">Copyright Statement</a></h3>
                    <p><div class="content_para"><p>This NGC summary is based on the original guideline, which is copyrighted by the University of Michigan Health System (UMHS).</p></div></p>

            </div>
                <h2 id="99999" class="accordion-title section-99999 is-active" role="tab" aria-expanded="true"><a href="#">Disclaimer</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">NGC Disclaimer</a></h3>
                    <p><p>The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.</p> 
<p>All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.</p> 
<p>Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the <a href="/web/20180712183206/https://www.guideline.gov/help-and-about/summaries/inclusion-criteria">NGC Inclusion Criteria</a>.</p> 
<p>NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding guideline content are directed to contact the guideline developer.</p></p>

            </div>

    </div>
    <!-- /.accordion-container -->

<!-- ASIDE -->
<!-- FOOTER -->






		</div><!-- /.article -->

	</div><!-- /.content -->

	
			<div class="aside">
				

    <!-- About NGC -->
    <div class="info-block">
            <h3 class="info prefix-icon large-icon">About NGC Guideline Summaries</h3>
            <p>NGC provides structured summaries containing information from clinical practice guidelines.</p>
            <ul>
                <li><a href="/web/20180712183206/https://www.guideline.gov/help-and-about/summaries/inclusion-criteria" class="internal-link">Inclusion Criteria</a></li>
                <li><a href="/web/20180712183206/https://www.guideline.gov/help-and-about/summaries/template-of-guideline-attributes" class="internal-link">Template of Guideline Attributes</a></li>
                <li><a href="/web/20180712183206/https://www.guideline.gov/help-and-about/summaries/classification-scheme" class="internal-link">Classification Scheme</a></li>
            </ul>
            <p><a href="/web/20180712183206/https://www.guideline.gov/help-and-about/summaries/faqs" class="help-button">Guideline Summary FAQs</a></p>

    </div>
    <!-- /info-block -->

    <!-- Guideline Synthesis -->

    <!-- HHS Block -->

    <!-- Related Content -->


    <hr>

    <!-- New on NGC -->
    <div class="subscribe-header">
        <h3 class="subscribe-title">New on NGC</h3>
        <ul class="subscribe-links">
            <li><a href="/web/20180712183206/https://www.guideline.gov/subscribe" class="newsletter"><span class="subscribe-links-label">Get Email Alerts</span></a></li>
            <li><a href="/web/20180712183206/https://www.guideline.gov/rssFiles/ngc_newthisweek.xml" class="rss"><span class="subscribe-links-label">RSS Feed</span></a></li>
        </ul>
    </div>
    <!-- /.subscribe-header -->
        <h5 class="prefix-icon guideline news-list-category-label">Guideline Summaries</h5>
        <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011378</li>
            <li>2017 Oct</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712183206/https://www.guideline.gov/summaries/summary/51300/mental-health-care-in-the-perinatal-period-australian-clinical-practice-guideline">Mental health care in the perinatal period: Australian clinical practice guideline.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011372</li>
            <li>2015</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712183206/https://www.guideline.gov/summaries/summary/51294/clinical-practice-guideline-on-systemic-lupus-erythematosus">Clinical practice guideline on systemic lupus erythematosus.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011385</li>
            <li>2018 Mar</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712183206/https://www.guideline.gov/summaries/summary/51326/vadod-clinical-practice-guideline-for-the-management-of-pregnancy">VA/DoD clinical practice guideline for the management of pregnancy.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011376</li>
            <li>2018 Feb</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712183206/https://www.guideline.gov/summaries/summary/51298/clinical-pharmacogenetics-implementation-consortium-cpic-guideline-for-dihydropyrimidine-dehydrogenase-genotype-and-fluoropyrimidine-dosing-2017-update">Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing: 2017 update.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011370</li>
            <li>2017 Dec</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712183206/https://www.guideline.gov/summaries/summary/51292/the-implementation-of-targeted-temperature-management-an-evidencebased-guideline-from-the-neurocritical-care-society">The implementation of targeted temperature management: an evidence-based guideline from the Neurocritical Care Society.</a></p>
    </div>

    <a class="block-link" href="/web/20180712183206/https://www.guideline.gov/new-this-week/index">
        <h3>New This Week </h3>
        <p>View more and sign up for our Newsletter</p>
    </a>
    <!-- Adobe Reader -->
    <p><a href="/web/20180712183206/https://www.guideline.gov/disclaimer?id=46415&amp;contentType=summary&amp;redirect=http%3A%2F%2Fget.adobe.com%2Freader%2F" class="external-link">Get Adobe Reader</a></p>

			</div><!-- /.aside -->
		</div><!-- /.aside-container -->

	<!-- BACK TO TOP -->
	
	
	



    <!-- COMMENTS -->
    

</div><!-- /.main -->

	</main>

	<!-- FOOTER -->
	<div class="footer" id="footer">

		<div class="footer-grid-container">
			<!-- Header -->
			<div class="footer-header">
				<a href="#" class="footer-logo">
			 		<picture>
					  	<source type="image/svg+xml" srcset="/web/20180712183206im_/https://www.guideline.gov/UI/images/logo_NGC_footer.svg">
					  	<img src="/web/20180712183206im_/https://www.guideline.gov/UI/images/logo_NGC_footer.png" alt="NGC">
					</picture>
				</a>
			</div><!-- /.footer-header -->

			<!-- Content -->
			<div class="footer-content">
				<div class="footer-nav">
					<ul class="level-1">
						<li><a href="/web/20180712183206/https://www.guideline.gov/">Home</a></li>
		                <li><a href="/web/20180712183206/https://www.guideline.gov/new-this-week/index">New This Week</a></li>
						<li><a href="/web/20180712183206/https://www.guideline.gov/browse/organization" class="parent-link">Guideline Summaries</a></li>
<li><a href="/web/20180712183206/https://www.guideline.gov/syntheses/index">Guideline Syntheses</a></li>						<li><a href="/web/20180712183206/https://www.guideline.gov/expert">Expert Commentaries</a></li>
		                <li><a href="/web/20180712183206/https://www.guideline.gov/matrix">Matrix Tool</a></li>
						<li><a href="/web/20180712183206/https://www.guideline.gov/summaries/submit">Submit Guidelines</a></li>
						<li><a href="/web/20180712183206/https://www.guideline.gov/help-and-about">Help &amp;&nbsp;About</a></li>
					</ul>
					<ul class="level-2">
						<li><a href="/web/20180712183206/https://www.guideline.gov/contact-us">Contact Us</a></li>
						<li><a href="/web/20180712183206/https://www.guideline.gov/rss">RSS</a></li>
					    <li><a href="/web/20180712183206/https://www.guideline.gov/site-map">Site Map</a></li>
                        <li><a href="/web/20180712183206/https://www.guideline.gov/browse/related">Related NQMC Measures</a></li>
                        <li><a href="/web/20180712183206/https://www.guideline.gov/help-and-about/about/editorial-board">Editorial Board</a></li>
                        <li><a href="/web/20180712183206/https://www.guideline.gov/help-and-about/general/web-site-credits">Web Site Credits</a></li>
                        <li><a href="/web/20180712183206/https://www.guideline.gov/help-and-about/general/disclaimer">Disclaimer</a></li>
						<li><a href="/web/20180712183206/https://www.guideline.gov/help-and-about/general/privacy">Privacy Policy</a></li>
                        <li><a href="/web/20180712183206/https://www.guideline.gov/help-and-about/technical/accessibility">Accessibility</a></li>	
                        <li><a href="/web/20180712183206/https://www.guideline.gov/help-and-about/technical/for-web-developers">For Web Developers</a></li>
					</ul>
				</div><!-- /.footer-nav -->
			</div><!-- /.footer-content -->

			<!-- Aside -->
			<div class="footer-aside">
				<h5 class="footer-partner-link-header">Visit our partner sites</h5>
				<ul class="footer-partner-links">
				    <li><!-- NQMC footer link -->
						<a href="https://web.archive.org/web/20180712183206/https://www.qualitymeasures.ahrq.gov/" target="_blank" class="partner-button nqmc">
							<span class="partner-logo">
								<picture>
							    	<source type="image/svg+xml" srcset="/web/20180712183206im_/https://www.guideline.gov/UI/images/logo_footerlink_nqmc.svg">
									<img src="/web/20180712183206im_/https://www.guideline.gov/UI/images/logo_footerlink_nqmc.png" alt="National Quality Measures Clearinghouse"/>
								</picture>
							</span>
						</a>
					</li><!--/MQMC footer Link -->
					<li><!-- HHS footer link --> 
						<a href="https://web.archive.org/web/20180712183206/https://www.qualitymeasures.ahrq.gov/hhs/index.aspx" target="_blank" class="partner-button hhs">
							<span class="partner-logo">
								<picture>
								    <source type="image/svg+xml" srcset="/web/20180712183206im_/https://www.guideline.gov/UI/images/logo_footerlink_hmis.svg">
								    <img src="/web/20180712183206im_/https://www.guideline.gov/UI/images/logo_footerlink_hmis.png" alt="HHS Measures Inventory"/>
								</picture>
							</span>
						</a>
					</li><!--/HHS footer link -->
				</ul>
			</div><!-- /.footer-aside -->

		</div><!-- /.footer-grid-container -->

	</div><!-- /.footer -->

	
	<!-- AHRQ FOOTER -->
	<div id="ahrq-footer">

		<!-- FIRST -->
		<div class="ahrq-first-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<p><a href="https://web.archive.org/web/20180712183206/http://www.ahrq.gov/index.html" class="ahrq-footer-logo" target="_blank">AHRQ</a></p>
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180712183206/http://www.ahrq.gov/policy/electronic/accessibility/index.html" target="_blank">Accessibility</a></li>
						<li><a href="https://web.archive.org/web/20180712183206/http://www.ahrq.gov/policy/electronic/disclaimers/index.html" target="_blank">Disclaimers</a></li>
						<li><a href="https://web.archive.org/web/20180712183206/http://www.ahrq.gov/policy/eeo/index.html" target="_blank">EEO</a></li>
						<li><a href="https://web.archive.org/web/20180712183206/http://www.ahrq.gov/policy/foia/index.html" target="_blank">FOIA</a></li>
						<li><a href="https://web.archive.org/web/20180712183206/http://www.hhs.gov/web/governance/digital-strategy/index.html" target="_blank">HHS Digital Strategy</a></li>
						<li><a href="https://web.archive.org/web/20180712183206/http://oig.hhs.gov/" target="_blank">Inspector General</a></li>
						<li><a href="https://web.archive.org/web/20180712183206/http://www.ahrq.gov/policy/electronic/plain-writing/index.html" target="_blank">Plain Writing Act</a></li>
						<li><a href="https://web.archive.org/web/20180712183206/http://www.ahrq.gov/policy/electronic/privacy/index.html" target="_blank">Privacy Policy</a></li>
						<li><a href="https://web.archive.org/web/20180712183206/http://www.ahrq.gov/policy/electronic/about/policyix.html" target="_blank">Electronic Policies</a></li>
						<li><a href="https://web.archive.org/web/20180712183206/http://www.hhs.gov/plugins.html" target="_blank">Viewers &amp; Players</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<h3>Get Social</h3>
					<ul class="ahrq-social">
						<li><a href="https://web.archive.org/web/20180712183206/http://www.facebook.com/" target="_blank" class="facebook"><span class="screen-reader-text">Facebook</span></a></li>
						<li><a href="https://web.archive.org/web/20180712183206/http://www.twitter.com/" target="_blank" class="twitter"><span class="screen-reader-text">Twitter</span></a></li>
						<li><a href="https://web.archive.org/web/20180712183206/http://www.linkedin.com/" target="_blank" class="linkedin"><span class="screen-reader-text">LinkedIn</span></a></li>
						<li><a href="https://web.archive.org/web/20180712183206/http://www.youtube.com/" target="_blank" class="youtube"><span class="screen-reader-text">YouTube</span></a></li>
					</ul>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.first-footer -->

		<!-- SECOND -->
		<div class="ahrq-second-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<ul>
						<li><a href="https://web.archive.org/web/20180712183206/http://www.ahrq.gov/index.html" target="_blank" class="ahrq-footer-home-link"><span class="screen-reader-text">AHRQ Home</span></a></li>
						<li><a href="https://web.archive.org/web/20180712183206/http://www.ahrq.gov/cpi/about/index.html" target="_blank">About Us</a></li>
						<li><a href="https://web.archive.org/web/20180712183206/http://www.ahrq.gov/cpi/about/careers/index.html" target="_blank">Careers</a></li>
						<li><a href="https://web.archive.org/web/20180712183206/http://www.ahrq.gov/contact/index.html" target="_blank">Contact Us</a></li>
						<li><a href="https://web.archive.org/web/20180712183206/http://www.ahrq.gov/Sitemap.html" target="_blank">Sitemap</a></li>
						<li><a href="https://web.archive.org/web/20180712183206/https://info.ahrq.gov/" target="_blank">FAQ</a></li>
					</ul>	
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180712183206/http://www.ahrq.gov/health-care-information/index.html" target="_blank">Health Care Information</a></li>
						<li><a href="https://web.archive.org/web/20180712183206/http://www.ahrq.gov/patients-consumers/index.html" target="_blank">For Patients &amp; Consumers</a></li>
						<li><a href="https://web.archive.org/web/20180712183206/http://www.ahrq.gov/professionals/index.html" target="_blank">For Professionals</a></li>
						<li><a href="https://web.archive.org/web/20180712183206/http://www.ahrq.gov/policymakers/index.html" target="_blank">For Policymakers</a></li>
						<li><a href="https://web.archive.org/web/20180712183206/http://www.ahrq.gov/research/index.html" target="_blank">Research Tools &amp; Data</a></li>
						<li><a href="https://web.archive.org/web/20180712183206/http://www.ahrq.gov/funding/index.html" target="_blank">Funding &amp; Grants</a></li>
						<li><a href="https://web.archive.org/web/20180712183206/http://www.ahrq.gov/cpi/index.html" target="_blank">Offices, Centers &amp; Programs</a></li>
						<li><a href="https://web.archive.org/web/20180712183206/http://www.ahrq.gov/news/index.html" target="_blank">News &amp; Events</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<ul>
						<li><a href="https://web.archive.org/web/20180712183206/http://www.hhs.gov/" target="_blank">U.S. Department of Health &amp; Human Services</a></li>
						<li><a href="https://web.archive.org/web/20180712183206/http://www.whitehouse.gov/" target="_blank">The White House</a></li>
						<li><a href="https://web.archive.org/web/20180712183206/http://www.usa.gov/" target="_blank">USA.gov: The U.S. Government's Official Web Portal   </a></li>
					</ul>
					<p class="ahrq-address">
						<strong>Agency for Healthcare Research&nbsp;and&nbsp;Quality</strong>
					    <br/>5600 Fishers Lane
					    <br/>Rockville, MD 20857
					    <br/><strong>Telephone:</strong> (301) 427-1364
					</p>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.second-footer -->
	</div><!-- /#ahrq-footer -->


	
	<!-- SCRIPTS -->
	
<script src="//web.archive.org/web/20180712183206js_/https://ajax.googleapis.com/ajax/libs/jquery/1.6.3/jquery.min.js" type="text/javascript"></script>
<script type="text/javascript">
if(!window.jQuery){
document.write('<script src="/cassette.axd/script/cdd67f922f9d413eaccb759182297335f87c3ff7/UI/js/jquery.js" type="text/javascript"><\/script>');
}
</script>
<script src="/web/20180712183206js_/https://www.guideline.gov/cassette.axd/script/595952c286b7fd52f0737b6f62085709be93156a/bodyJS" type="text/javascript"></script>

    
</body>
</html>
<!--
     FILE ARCHIVED ON 18:32:06 Jul 12, 2018 AND RETRIEVED FROM THE
     INTERNET ARCHIVE ON 16:33:07 Jul 15, 2018.
     JAVASCRIPT APPENDED BY WAYBACK MACHINE, COPYRIGHT INTERNET ARCHIVE.

     ALL OTHER CONTENT MAY ALSO BE PROTECTED BY COPYRIGHT (17 U.S.C.
     SECTION 108(a)(3)).
-->
<!--
playback timings (ms):
  LoadShardBlock: 455.744 (3)
  esindex: 0.01
  captures_list: 476.511
  CDXLines.iter: 15.445 (3)
  PetaboxLoader3.datanode: 115.612 (4)
  exclusion.robots: 0.17
  exclusion.robots.policy: 0.159
  RedisCDXSource: 1.675
  PetaboxLoader3.resolve: 327.219 (4)
  load_resource: 92.761
-->